Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin After Large Myocardial Infarction (REVEAL) trial

BACKGROUND: Acute myocardial infarction (MI) remains a leading cause of death despite advances in pharmacologic and percutaneous therapies. Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin (EPO) may reduce infarct size, decrease apoptosis, and increase neovascu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Melloni, Chiara, Rao, Sunil V., Povsic, Thomas J., Melton, Laura, Kim, Raymond J., Kilaru, Rakhi, Patel, Manesh, Talan, Mark, Ferrucci, Luigi, Longo, Dan L., Lakatta, Edward G., Najjar, Samer S., Harrington, Robert A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018783/
https://ncbi.nlm.nih.gov/pubmed/21095264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2010.09.007
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items